Our Core Team.

We’re a team of scientists and builders at the edge of synthetic biology and genetic engineering. With a focus on hands-on innovation and platform development, we’re designing therapeutic technologies from the ground up to tackle cancer in entirely new ways.

Join The Team

Co-Founder, CEO, Board Chair

Dylan Paoletti

Biotech innovator with a background in genetic engineering and scientific presentation; leads company & product vision, R&D, and company strategy.

Co-Founder, CSO, CFO

Dr. Peter Evans

Former FDA scientist with expertise in molecular biology and public health. Oversees R&D, operations, finances, and regulatory planning.

Principal Scientist

Dr. Yildrim Dogan

Former director at Moderna and AVROBIO. Cancer research and gene therapy development and clinical translation expertise.

Better Genes.
Better Outcomes.

Your next-generation therapeutics platform for precision oncology.

We Are Visionaries

We’re reprogramming cancer from the inside out. Genetic Circuit Therapeutics develops modular genetic circuits to treat aggressive cancers like Small cell lung cancer (SCLC), Triple negative breast cancer (TNBC), and High-grade serous ovarian cancer (HGSOC) by restoring cellular function and triggering apoptosis.